Doorenbos CJ - Search Results

1

Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.

van Berlo-van de Laar IR, Vermeij CG, Doorenbos CJ. van Berlo-van de Laar IR, et al. Among authors: doorenbos cj. J Clin Pharm Ther. 2011 Jun;36(3):376-82. doi: 10.1111/j.1365-2710.2010.01192.x. Epub 2010 Aug 25. J Clin Pharm Ther. 2011. PMID: 21545617

2

Use of urea containing dialysate to avoid disequilibrium syndrome, enabling intensive dialysis treatment of a diabetic patient with renal failure and severe metformin induced lactic acidosis.

Doorenbos CJ, Bosma RJ, Lamberts PJ. Doorenbos CJ, et al. Nephrol Dial Transplant. 2001 Jun;16(6):1303-4. doi: 10.1093/ndt/16.6.1303. Nephrol Dial Transplant. 2001. PMID: 11390747 No abstract available.

3

Bicarbonate-lactate peritoneal dialysis in a patient with a mitochondriopathy.

Doorenbos CJ. Doorenbos CJ. Perit Dial Int. 2001 Sep-Oct;21(5):518-9. Perit Dial Int. 2001. PMID: 11757838 No abstract available.

4

Danger of salt substitutes that contain potassium in patients with renal failure.

Doorenbos CJ, Vermeij CG. Doorenbos CJ, et al. BMJ. 2003 Jan 4;326(7379):35-6. doi: 10.1136/bmj.326.7379.35. BMJ. 2003. PMID: 12511461 Free PMC article. No abstract available.

5

The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptors.

Blauw GJ, van Brummelen P, Doorenbos CJ, van der Velde EA, van Zwieten PA. Blauw GJ, et al. Among authors: doorenbos cj. Clin Pharmacol Ther. 1991 Apr;49(4):377-84. doi: 10.1038/clpt.1991.44. Clin Pharmacol Ther. 1991. PMID: 1849810 Clinical Trial.

6

Patients' representations of their end-stage renal disease: relation with mortality.

van Dijk S, Scharloo M, Kaptein AA, Thong MS, Boeschoten EW, Grootendorst DC, Krediet RT, Dekker FW; NECOSAD Study Group, Apperloo AJ, Bijlsma JA, Boekhout M, Boer WH, van der Boog PJ, Büller HR, van Buren M, de Charro FT, Doorenbos CJ, van den Dorpel MA, van Es A, Fagel WJ, Feith GW, de Fijter CW, Frenken LA, van Geelen JA, Gerlag PG, Grave W, Gorgels JP, Huisman RM, Jager KJ, Jie K, Koning-Mulder WA, Koolen MI, Hovinga TK, Lavrijssen AT, Luik AJ, van der Meulen J, Parlevliet KJ, Raasveld MH, van der Sande FM, Schonck MJ, Schuurmans MM, Siegert CE, Stegeman CA, Stevens P, Thijssen JG, Valentijn RM, Vastenburg GH, Verburgh CA, Vincent HH, Vos PF. van Dijk S, et al. Among authors: doorenbos cj. Nephrol Dial Transplant. 2009 Oct;24(10):3183-5. doi: 10.1093/ndt/gfp184. Epub 2009 Apr 21. Nephrol Dial Transplant. 2009. PMID: 19383834

7

Antihypertensive treatment with ketanserin shows no evidence of vascular serotonin2-receptor and alpha 1-adrenoceptor blockade.

Blauw GJ, Doorenbos CJ, Bruning TA, van Brummelen P, van Zwieten PA. Blauw GJ, et al. Among authors: doorenbos cj. Drugs. 1990;40 Suppl 4:42-4. doi: 10.2165/00003495-199000404-00011. Drugs. 1990. PMID: 1982654 No abstract available.

8

Arterial and venous effects of atrial natriuretic peptide in the human forearm.

Doorenbos CJ, Blauw GJ, van Brummelen P. Doorenbos CJ, et al. Am J Hypertens. 1991 Apr;4(4 Pt 1):333-40. doi: 10.1093/ajh/4.4.333. Am J Hypertens. 1991. PMID: 1829369

9

Enalapril-induced anemia in two kidney transplant recipients.

Graafland AD, Doorenbos CJ, van Saase JC. Graafland AD, et al. Among authors: doorenbos cj. Transpl Int. 1992 Mar;5(1):51-3. doi: 10.1007/BF00337190. Transpl Int. 1992. PMID: 1580986

10

Atrial natriuretic peptide and chronic renal effects of changes in dietary protein and sodium intake in man.

Doorenbos CJ, Iestra JA, Papapoulos SE, Odink J, Van Brummelen P. Doorenbos CJ, et al. Clin Sci (Lond). 1990 Jun;78(6):565-72. doi: 10.1042/cs0780565. Clin Sci (Lond). 1990. PMID: 2165888 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results